Biogen Inc. (BIIB)

264.80
NASDAQ
Prev Close 270.21
Day Low/High 264.35 / 270.37
52 Wk Low/High 223.25 / 468.55
Exchange NASDAQ
Shares Outstanding 146.89B
Market Cap 39.69B
P/E Ratio 8.89
Div & Yield N.A. (N.A)

Latest News

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

Real Money Post Industrial Average Outperforms for the Quarter

Real Money Post Industrial Average Outperforms for the Quarter

RMPIA for the September-ending quarter is up .2%, outperforming most of the major market indexes. Let's dig in.

There's Good News for 3 Biotech Names

There's Good News for 3 Biotech Names

And It comes after one of the best days of the year for the biotech sector.

Jim Cramer: Why Hasn't the Government Pushed for Mass Vaccination?

Jim Cramer: Why Hasn't the Government Pushed for Mass Vaccination?

Incompetence, omissions and even outright lies have categorized this federal attempt to 'stem' the pandemic.

Jim Cramer: This Moment Is One of the Toughest I Have Seen in Corporate America

Jim Cramer: This Moment Is One of the Toughest I Have Seen in Corporate America

The stock market's rise might have ended after the cliff, not before it.

Crypto Pep Rally, S&P Wonder Line, Minerd Unmuted, Chip Keepers, Trading Moderna

Crypto Pep Rally, S&P Wonder Line, Minerd Unmuted, Chip Keepers, Trading Moderna

Small-caps and mid-caps are still picking first downs on every play, storming back from a badly oversold condition that has just about normalized.

Jim Cramer: It's a Jailbreak and the Stocks Are Busting Out

Jim Cramer: It's a Jailbreak and the Stocks Are Busting Out

This market is moving in so many areas that you have to marvel at how it's even possible -- even if the Russell Rebalancing could change all that on Friday.

Rotation and Late-Day Strength Cover Up Mixed Action Underneath

Rotation and Late-Day Strength Cover Up Mixed Action Underneath

Odd mix of moves precedes one of the most important Fed meetings in a while.

Biogen Raised to Outperform at Bernstein

2 Small Biotech Stocks That Could See Big Gains Ahead

2 Small Biotech Stocks That Could See Big Gains Ahead

BioXcel Therapeutics and Albiero Pharma have promising prospects based on drugs in their pipelines.

Biogen's Japanese Partner on Alzheimer's Drug Set for Gains

Biogen's Japanese Partner on Alzheimer's Drug Set for Gains

Eisai is working on another promising drug candidate to combat Alzheimer's disease, and will benefit from a split of the profits for Aduhelm.

Updating Our Biogen Targets as It Soars on Alzheimer Drug Approval

Updating Our Biogen Targets as It Soars on Alzheimer Drug Approval

Traders who went long BIIB on our April recommendation should continue to hold those shares.

Biogen Starts to Make Its Upside Move as Decision on Alzheimer's Drug Awaits

Biogen Starts to Make Its Upside Move as Decision on Alzheimer's Drug Awaits

The drugmaker's charts are pointing to higher ground for its shares as a regulatory decision on its Alzheimer's drug aducanumab is at hand.

The Hour Glass Phenomena, Oh Canada, Portfolio Haircut, Earth Day, ESG Investing

The Hour Glass Phenomena, Oh Canada, Portfolio Haircut, Earth Day, ESG Investing

Canada made the developed world's first moves toward normalizing monetary policy coming out of the pandemic, despite the fact that Canada does not seem to be flattening its own curve.

Biogen's Charts Are Ready for an Upside Breakout

Biogen's Charts Are Ready for an Upside Breakout

Here's our first price objective.

Shock & Awe Markets, Bank Stocks, Apple's Debt Move, Trading Amazon, ServiceNow

Shock & Awe Markets, Bank Stocks, Apple's Debt Move, Trading Amazon, ServiceNow

Right off the top, the bubble has burst for the 'short squeeze' names such as GameStop and AMC Entertainment.

Real Money Post Industrial Average Feels January Chill

Real Money Post Industrial Average Feels January Chill

The RMPIA easily outpaced the main indexes for 2020, but slipped 1.7% last month.

Real Money Post Industrial Average Bests Most Major Indexes in 2020

Real Money Post Industrial Average Bests Most Major Indexes in 2020

As we enter the new year, there's little time to reflect on RMPIA's strong performance. Now, it's all eyes on the 12 months ahead of us.

Real Money Post Industrial Average Climbs 9.5% Over November

Real Money Post Industrial Average Climbs 9.5% Over November

The RMPIA also tops other indexes for year, shooting ahead 29%.

Bearish Bets: 2 Biotech Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Biotech Stocks You Should Consider Shorting This Week

These names are displaying both technical and quantitative deterioration.

Real Money Post Industrial Average Rises 21% Year to Date

Real Money Post Industrial Average Rises 21% Year to Date

The average declined in October, but it was less than that hit took by the major indexes.

The Market Is Shrugging Off the Political News

The Market Is Shrugging Off the Political News

And that is helping to create fear of missing out.

'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed

'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed

There is a presidential debate on Thursday. The market is being forced to adjust for renewed potential uncertainty.

Immatics Is a Bit Boy Who Cried Wolf

Immatics Is a Bit Boy Who Cried Wolf

This is the type of chart that will grab the attention of momentum traders.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

2 Biotech Stocks to Buy on Solid Q2 Results

2 Biotech Stocks to Buy on Solid Q2 Results

Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.